期刊文献+

HPLC测定多柔比星壳寡糖硬脂酸胶团中药物的含量 被引量:1

HPLC Determination of Doxorubicin Concentration in Chitosan Oligosaccharide-stearic Acid Micelles
原文传递
导出
摘要 目的采用高效液相色谱法测定壳寡糖硬脂酸嫁接物胶团(CSO-SA)中的多柔比星(DOX)的含量。方法采用Shim-pack VP-ODS色谱柱(150mm×4.6mm,5μm),以0.01mol·L-1的十二烷基硫酸钠溶液-乙腈-甲醇(50∶50∶6)为流动相,内含0.6‰(v/v)的磷酸,流速1.0mL·min-1,检测波长254nm,柱温25℃。结果多柔比星在0.4~8μg·mL-1时,浓度与峰面积呈良好的线性关系,Y=52.926X-3.761(r=0.9999,n=3),定量限为(0.05±0.014)μg·mL-1(S/N>10,n=3)。高、中、低三个浓度的日内RSD为1.82%、0.86%、0.65%,日间RSD为1.73%、0.88%、0.75%,平均加样回收率为(99.38±1.22)%。结论本测定方法操作简便,结果准确。 OBJECTIVE An HPLC analysis method was established for the determination of doxorubicin (DOX) concentration in chitosan oligosaccharide-stearic acid (CSO-SA) micelles. METHODS The segregation and determination of samples were performed on a Shim pack VP-ODS (150 mm ×4.6 mm, 5 μm) column with a mobile phase consisting of 0.01 mol·L^-1 sodium dodecyl sulfate-methanol-acetonitrile (50 : 50 : 6) containing 0.6‰ phosphoric acid at a flow-rate of 1.0 mL-min^-1, UV detector was set at 254 nm and column temperature was 25 ℃.RESULTS There was good linear relationship within the range of 0.4-8 μg·mL^-1 of DOX, Y=52.926X-3.761 (r=0.999 9, n=3) . The quantification limit was (0.05±0.014) μg.mL^-1(S/N〉10, n=3). The RSDs of within-day were 1.82, 0.86, 0.65% ,and the RSDs of between-day were 1.73%, 0.88%, 0.75%, respectively.The average recovery was(99.38 ±.22)%.CONCLUSION The HPLC methods are simple and accurate for the doxorubicin concentration in micellar delivery system.
机构地区 浙江大学药学院
出处 《中国现代应用药学》 CAS CSCD 北大核心 2009年第5期388-390,共3页 Chinese Journal of Modern Applied Pharmacy
基金 国家自然科学基金资助项目(30672552) 863科技计划项目(2007AA03z318) 浙江省教育厅科研基金资助项目(20061326)
关键词 多柔比星 高效液相色谱法 壳寡糖硬脂酸嫁接物胶团 doxorubicin HPLC chitosan oligosaccharide-stearic acid micelles
  • 相关文献

参考文献8

二级参考文献25

  • 1[1]Jones M, Leroux J. Polymeric micelles-a new generation of colloidal drug carriers [ J ]. Eur J Pharm Biopharm, 1999, 48(2) :101 - 111.
  • 2[2]Muranishi S. Absorption enhancers [ J ]. Crit Rev Ther Drug Carrier Syst, 1990, 7( 1 ) :1 -33.
  • 3[3]Vladimir P. Torchilin. PEG-based micelles as carriers of contrast agents for different imaging modalites [ J ]. Adv Drug Deliv Rev, 2002, 54(2) :235 - 252.
  • 4[4]De Campos AM, Sanchez A, Alonso MJ. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface [ J ]. Int J Pharm, 2001, 224( 1 -2) :159 - 168.
  • 5[5]Zhang Q, Yie G, Li Y, et al. Studies on the cyclosporin A loaded stearic acid nanoparticles [ J]. Int J Pharm, 2000, 200(2): 153 - 159.
  • 6[6]Andres BS, Martina EK. Mucoadhesive polymers as platforms for peroral peptide delibery and absorption: synthesis and evalution of different chitosan-EDTA conjugates [ J ]. J Controlled Release, 1998, 50 (2 - 3 ): 215 -223.
  • 7[7]Lee KY, Kwon IC, Kim YH, et al. Preparation of chitosan self-aggregates as a gene delivery system. [ J ]. J Controlled Release, 1998, 51 ( 2 - 3 ) :213 - 220.
  • 8[8]Shu XZ, Zhu KJ. Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure [ J ]. Int J Pharm, 2002, 233 ( 1 - 2): 217 -225.
  • 9[9]Kataoka K, Ishihara A, Harada A, et al, Effect of secondary structure of poly (L-lysine) segments on the micellization of poly ( ethylene glycol ) -poly ( L-lysine ) block copolymer partially substituted with hydrocinnamoyl group at the N-position in aqueous milieu [ J ]. Macromolecules, 1998, 31:6071 - 6076.
  • 10[10]Park SB, You JO, Park HY, et al. A novel pH-sensitive membrane from chitosan-TEOS-IPN: preparation and its drug permeation characteristics [ J ]. Biomaterials, 2001, 22(4) :323 -330.

共引文献33

同被引文献4

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部